Acura Pharmaceuticals Common Stock To Trade On The OTCQB ... - GlobeNewswire (press release)
PALATINE, Ill., Feb. 15, 2017 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (NASDAQ:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that shares of its common stock will begin to trade on the OTCQB® ...altro »
ACURA PHARMACEUTICALS, INC. (NASDAQ:ACUR) Files An 8-K ... - Market Exclusive
On February 24, 2017, we increased the maximum bonus payable to Albert W. Brzeczko, Vice President Technical Affairs of our subsidiary Acura Pharmaceutical Technologies, Inc. from 35% to 50% of base salary under our non-equity bonus incentive plan.altro »
Forward Earnings Estimate of Acura Pharmaceuticals, Inc.(ACUR) - Highland Mirror
Acura Pharmaceuticals, Inc. has received $-0.27 as the consensus Earnings Estimate for the Quarter ending on Dec 2016 ,According to the estimate provided by 1 Financial Advisor in the Stock Trading Firms. The EPS growth rate is projected at -237.5%.
Review of Price Trends: Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) - Is stories
Acura Pharmaceuticals, Inc.'s (ACUR) witnessed a loss of -3.23% in recent trading period with closing price of $ 0.60. The company's last traded volume of 0.19 million shares as compared to it's an average volume of 0.57 million shares. In the trailing ...altro »
Tuesday's Midday Stock Update: Acura Pharmaceuticals (ACUR ... - Analyst Ratings
Acura Pharmaceuticals is up 36.76% in midday trading to $0.68. Shares opened today at $0.50. The company has a 52-week low of $0.50 and a 52-week high of $3.52. Over the last 3 months, the insider sentiment on Acura Pharmaceuticals has been neutral ...
Critical Chart Information For Acura Pharmaceuticals, Inc. (ACUR) - NY Stock News
The technicals for Acura Pharmaceuticals, Inc. (ACUR) have taken shape, and with them a comprehensive picture has emerged. ... The result has been the mass-proliferation of confusion and less and less attention to the fundamentals of trading success.altro »
Analyst Recommendations And Earnings Forecast: Acura ... - Post Analyst
Acura Pharmaceuticals, Inc. (ACUR) has made its way to a 12-month decline of -46.08%. Turning to Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), its shares were trading at $0.59 a gain of $0.02, on the trading floor. The stock, after opening at $0 ...
A Look Ahead For 2 Stocks: InvenSense, Inc. (INVN), Acura ... - Post Analyst
InvenSense, Inc. (NYSE:INVN) last session's volume of 1.63 million shares was lower than its average volume of 3.54 million shares. The stock, after opening at ...altro »
Analyst Observation On 2 Stocks: Radius Health, Inc. (RDUS), Acura ... - Post Analyst
Radius Health, Inc. (NASDAQ:RDUS) last session's volume of 1.31 million shares was higher than its average volume of 0.76 million shares. The stock, after ...altro »
Trending Stock Analysis Report: Acura Pharmaceuticals, Inc ... - TopChronicle
Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) traded with the volume of 5.14 Million in the previous trading session. The Stock opened its session at $1 and closed at $0.92 by showing decrease of -29.23 percent. Acura Pharmaceuticals, Inc. has 1 year price ...